Intersect ENT Receives $30,000,000 Series C Financing

  • Feed Type
  • Date
  • Company Name
    Intersect ENT
  • Mailing Address
    1049 Elwell Court Palo Alto, CA 94303
  • Company Description
    Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series C
  • Proceeds Purposes
    Intersect ENT intends to use the proceeds to commercialize its initial product as well as build a portfolio of products for conditions treated by Ear, Nose, & Throat (ENT) surgeons.
  • M&A Terms
  • Venture Investor
  • Venture Investor
    PTV Sciences
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    U.S. Venture Partners

Trending on Xconomy